ghk-cu immunogenicity compared to other peptides antibody formation or risk An evidence-based strategy for assessing the of Implementing a Clinical Immunogenicity Strategy – The tri-peptide GHK-Cu complex ameliorates – antibody formation ghk-cu immunogenicity responses – ghk-cu immunogenicity or antibody formation

Product specifications CAS Registry Number 885340-08-9344 Reported purity 98.5% Form Lyophilized laboratory research material Intended use Qualified in vitro laboratory research only

****Information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment

The FDA issued a warning letter in 2014

Getting started is simpler than you'd think, with no commitment until you understand your options: 5-Amino-1MQ is a small molecule, often grouped with metabolic peptides, that inhibits the enzyme NNMT

Most users find the 0.25 to 0.5 mg daily range provides optimal results without diminishing returns from higher doses